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ABSTRACT 
 
Role of Repressors in Fine Regulation of Development: Sxl and Its New Repressors Hey 
and Myc. (December 2009) 
Elena Kozhina, B.S., Novosibirsk State University, Russia  
Chair of Advisory Committee: Dr. James Erickson 
 
In Drosophila, XX embryos express Sxl from the early promoter, SxlPe, and 
become females.  At the same time, XY embryos with only one X chromosome become 
males.  
I investigated the role of repression in the establishment of the strict regulation of 
SxlPe.  I found that the co-repressor Groucho, is responsible for amplification of the 
two-fold difference in X-encoded activator genes into an all-or-nothing difference in Sxl 
expression.  Three new basic helix-loop-helix repressors of Sxl were identified: Hey, 
Cwo and the prooncogene Myc, all of which are maternally supplied.  I have shown that 
Myc specific repression is important as early as cycle 10, which is 2 cycles earlier than 
the onset of normal Sxl expression. 
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1. INTRODUCTION*  
 
Role of Sxl repressors in sex determination in Drosophila 
Dose-sensitive promoters respond to small differences in regulatory protein 
concentrations to produce large differences in gene expression.  In some instances 
differential concentrations of activators alone appear to set promoters into their 
appropriate expression states, but the general rule is that the enhancers controlling 
switch-like promoters integrate concentration-dependent inputs from both activators 
and inhibitors to establish precise boundaries of expression (see (Mannervik et al., 
1999), (Barolo and Posakony, 2002), (Clyde et al., 2003) and (Ochoa-Espinosa et al., 
2005).  In the developing nervous systems of flies and vertebrates, for example, 
antagonistic interactions between negatively and positively-acting proteins of the basic-
helix–loop–helix, bHLH, family define the sharp boundaries of gene expression 
required for specification of neural precursor cells (reviewed in (Massari and Murre, 
2000).  Similar antagonistic interactions between bHLH proteins and their associated 
cofactors are hypothesized to play important roles in the specification of the alternative 
male and female fates in Drosophila.  
Chromosomal sex determination in Drosophila is a textbook example of how 
two-fold changes in transcriptional regulatory protein concentrations can elicit different 
developmental outcomes (reviewed by (Cline and Meyer, 1996) and (Ashburner et al.,  
___________ 
This thesis follows the style of Developmental Biology. 
*Reprinted from Developmental Biology 323(2), Lu H, Kozhina E, Mahadevaraju S, Yang D, Avila 
FW, Erickson JW, Maternal Groucho and bHLH repressors amplify the dose-sensitive X chromosome 
signal in Drosophila sex determination, 248-260, Copyright © 2008, with permission from Elsevier 
Inc.  
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2005). In the fly, the collective dose of four X chromosome-linked signal element genes, 
XSEs, conveys X chromosome dose to the master regulatory gene Sex-lethal, Sxl (Cline, 
1993) and (Erickson and Quintero, 2007)).  In XX embryos the double XSE dose directs 
the transient activation of the Sxl establishment promoter, SxlPe, initiating a positive 
autoregulatory splicing loop that operates on pre-mRNAs produced from the constitutive 
promoter, SxlPm, thereby maintaining Sxl in the on (female) state for the remainder of 
its life (Cline, 1984; Bell et al., 1991; Keyes et al., 1992; Nagengast et al., 2003).  In XY 
embryos, the single dose of XSEs leaves SxlPe inactive, precluding functional splicing 
of SxlPm-derived transcripts and thereby directing the male fate. 
 Three of the four XSE genes encode transcription factors that directly regulate 
SxlPe.  The two strongest XSEs, scute and sisA, encode bHLH and bZIP activators, 
while runt encodes the founding member of the RUNX class of DNA binding proteins 
(Cline, 1988; Cline and Meyer, 1996; Ashburner et al., 2005).  Although the dose-
sensitive XSE proteins are of central importance in the X-counting process, their direct 
action at SxlPe requires additional protein factors.  Maternally-supplied daughterless 
protein, for example, interacts with Scute to form the DNA binding bHLH heterodimer, 
Sc/Da, while maternally supplied STAT, and presumably, Bicoid stability factor, bind 
directly to SxlPe to facilitate expression (Yang et al., 2001; Bosch et al., 2006; Avila and 
Erickson, 2007; De Renzis et al., 2007).  How these and other factors work to effectively 
amplify the two-fold difference in XSE dose into an all-or-nothing response at SxlPe is 
unknown.  Cooperative or combinatorial interactions among the XSE and maternal 
activators in protein assembly, DNA binding, or via interactions with the general 
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transcription machinery, have been offered as possible explanations of how male and 
female XSE concentrations might be reliably distinguished at SxlPe (Cline, 1993; 
Erickson and Cline, 1993; Yang et al., 2001).  Other models, however, focus on the 
means by which negative regulators might amplify the difference in XSE protein 
concentrations to generate a reliable sex-determining signal (see Parkhurst et al., 1990; 
Schutt and Nothiger, 2000; Gilbert, 2006).  
 Three negative regulators of SxlPe have been identified: the maternally supplied 
extramachrochetae (emc) and groucho (gro) products and the zygotically expressed 
product of the autosomal gene deadpan (dpn) (Younger-Shepherd et al., 1992; Paroush 
et al., 1994; Barbash and Cline, 1995).  Emc is an HLH protein that lacks a basic DNA-
binding domain and exerts its inhibitory effects by forming heterodimers with bHLH 
activators, such as Scute and Da, thereby preventing them from binding to DNA 
(Massari and Murre, 2000; Campuzano, 2001).  While emc apparently plays a minor role 
in sex determination (Younger-Shepherd et al., 1992), loss of maternal gro has been 
reported to cause male embryos to express female levels of Sxl protein, suggesting that 
Gro-mediated repression of SxlPe may be essential for distinguishing X chromosome 
dose (Paroush et al., 1994).  Gro is the archetypal example of the widely-distributed 
Gro/TLE family of transcriptional corepressors, that are recruited to DNA by virtue of 
their interactions with several different groups of sequence-specific DNA binding 
proteins; including bHLH repressors such as Dpn (reviewed in (Fisher and Caudy, 
1998a; Chen and Courey, 2000; Buscarlet and Stifani, 2007; Fischer and Gessler, 2007).  
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 The dpn gene was identified as an autosomal sex signal element, or ASE, 
because it functions as a zygotically expressed negative regulator of Sxl (Younger-
Shepherd et al., 1992; Barbash and Cline, 1995).  Present in equal amounts in XX and 
XY embryos the dpn product is needed to properly assess the male XSE dose as 
evidenced by the finding that loss of dpn function causes some XY cells to activate 
SxlPe and adopt the inappropriate female fate (Younger-Shepherd et al., 1992; Barbash 
and Cline, 1995).  Dpn is a member of the Hairy-Enhancer of split, HES, family of 
bHLH repressors (reviewed in Fisher and Caudy, 1998a; Massari and Murre, 2000; Iso 
et al., 2003; Fischer and Gessler, 2007; Kageyama et al., 2007).  HES proteins and the 
closely related HEY family (HES with YRPW) bind to the “E-box” CACGTG and the 
related sequence CACGCG, the later being the optimal sequence for Hairy and Dpn 
(Ohsako et al., 1994; Van Doren et al., 1994).  HES factors also bind with reduced 
affinity to the "N-box" CACRAG suggesting that there is a range of allowable in vivo 
target sites.   
 HES proteins repress transcription by several different mechanisms.  Best 
understood is the recruitment of the corepressor Gro to DNA via the C-terminal peptide 
sequence, WRPW, present in all HES family members (Paroush et al., 1994; Fisher et 
al., 1996; Fisher and Caudy, 1998a).  Some HES proteins recruit other corepressors such 
as CtBP and Sir2 to DNA and there is evidence that mutual antagonism between 
different corepressors can influence HES protein function (Poortinga et al., 1998; Zhang 
and Levine, 1999; Bianchi-Frias et al., 2004).  Repression may also be mediated directly 
by competition with activators for DNA binding or by sequestering bHLH activators 
 5
into inactive heterodimers (Fisher and Caudy, 1998a; Fischer and Gessler, 2007; 
Kageyama et al., 2007).  Most of these schemes have been invoked to explain how Dpn 
might function during sex determination (Paroush et al., 1994; Dawson et al., 1995; 
Jimenez et al., 1997), but none have been examined in detail.  
 Although Dpn is the only known DNA-binding repressor of SxlPe, loss of dpn 
function has a relatively mild effect, causing low-level ectopic activation of SxlPe in a 
subset of male nuclei (Barbash and Cline, 1995).  Given the efficiency of HES/Gro-
mediated repression in other contexts (Barolo and Levine, 1997; Zhang and Levine, 
1999; Courey and Jia, 2001) and the presence of two canonical CACGCG Dpn-binding 
sequences at SxlPe (Hoshijima et al., 1995; Winston et al., 1999), it is not clear why Dpn 
has such a modest effect on sex determination.  One possibility is that Dpn function 
could be modulated, perhaps by chemical modification (Karandikar et al., 2005), or by 
competition with other DNA binding proteins (Yang et al., 2001; Louis et al., 2003).  A 
second possibility is that additional repressors negatively regulate SxlPe: an explanation 
consistent with the report that loss of maternal gro function leads to high-levels of Sxl 
protein in XY embryos (Paroush et al., 1994). 
 To better understand the role of transcriptional repression in primary sex 
determination we characterized the cis-acting promoter elements recognized by Dpn, 
and analyzed the effects of maternal gro on SxlPe.  Our studies revealed that SxlPe 
contains three functional Dpn DNA-binding sites, including one with the non-canonical 
sequence CACACT.  Mutations in the Dpn-binding sites had stronger and earlier effects 
on SxlPe than did a null dpn mutation, suggesting that additional bHLH repressors 
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regulate SxlPe.  We found that the Hey locus encodes one such maternal-effect repressor 
of SxlPe, but that the E(spl)m3 gene, which had previously been proposed to regulate Sxl 
(Dawson et al., 1995; Poortinga et al., 1998), does not.  The gro product influences 
SxlPe earlier and more strongly than does dpn, suggesting that the initial concentrations 
of XSE proteins needed to activate SxlPe in XX embryos are defined by Gro-mediated 
repression and then modulated upward to compensate for rising XSE levels in XY 
embryos.  We propose a model for SxlPe regulation in which the XSE signal is 
amplified by a positive feedback mechanism that inhibits Gro-mediated repression in 
XX, but not XY, embryos. 
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2. MATERIALS AND METHODS* 
 
Immunohistochemistry and in situ hybridization 
 Cultivation, transfection, and assay of Schneider L2 cells were according to (Han 
et al., 1989).  One µg of DNA was used per plate and included:  0.1 µg of firefly 
luciferase Dpn-binding site reporter, 0.1 µg actin5Cp-dpn-VP16 expression construct, 
0.1 µg of SV40 -Renilla luciferase reporter to control for transfection efficiency (pRL-
SV40 Promega), and carrier DNA.  Luciferase activity was determined using a Dual-
Luciferase assay kit (Promega) and a Berthold Lumat LB9501 luminometer.   
Embryos were prepared for immunocytochemistry according to (Patel, 1994).  
Anti-Sxl mouse antibody was used as described (Erickson and Quintero, 2007).  All 
embryos were stained with DAPI to visualize DNA and mounted in 70% glycerol.  In 
situ hybridization was done using standard procedures including NBT/BCIP staining 
(Lehmann and Tautz, 1994).  Briefly, digoxygenin-labeled RNA probes complementary 
to Sxl exon E1, or lacZ sequences were prepared using in vitro transcription of plasmid 
or PCR-derived templates (Avila and Erickson, 2007; Erickson and Quintero, 2007).  Sxl 
exon E1 probes detect both SxlPe-derived mRNA and Pe-derived nascent transcripts, the 
later visible as dots of staining within nuclei (Shermoen and O'Farrell., 1991; Erickson 
and Cline, 1993; Barbash and Cline, 1995; Erickson and Cline, 1998; Erickson and 
Quintero, 2007).  For X-linked genes, or transgenes, the number of nuclear dots  
___________ 
*Reprinted from Developmental Biology 323(2), Lu H, Kozhina E, Mahadevaraju S, Yang D, Avila 
FW, Erickson JW, Maternal Groucho and bHLH repressors amplify the dose-sensitive X chromosome 
signal in Drosophila sex determination, 248-260, Copyright © 2008, with permission from Elsevier 
Inc.  
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corresponds to the number of X chromosomes.  Embryo cell cycles were determined by 
nuclei density (Foe et al., 1993).  Nuclei change in appearance through the cell cycle and 
we used this to closely stage embryos in cycles 11-13 (Edgar et al., 1994).  Times within 
cycle 14 were estimated by nuclear shape and length, and by the extent of membrane 
furrow invagination (Foe et al., 1993; Grosshans et al., 2003).  In wild-type females 
SxlPe expression begins during cycle 12.  In typical embryo collections, only one quarter 
of cycle 12 embryos (one half of XX embryos) express Sxl and many of those express in 
a mosaic pattern with individual nuclei exhibiting one, two, or no nuclear dots, reflecting 
stochastic activation of the promoter during cycle 12 (Erickson and Cline, 1998; 
Erickson and Quintero, 2007).  For heymat- we observed that 10/21 cycle 12 embryos 
exhibited Sxl staining from both X chromosomes in most, or all, nuclei. The number of 
Sxl-expressing cycle 12 heymat- embryos was not significantly different from wild-type 
(expected 5-6 with expression in some nuclei), but was consistent with our qualitative 
assessments of elevated staining levels in heymat- XX embryos, and is thus suggestive of 
a repressive effect of maternal Hey on SxlPe activation in females. 
Fly culture and genetics  
Flies were grown on standard medium in uncrowded conditions at 25oC.  
Mutations and chromosomes are described: http://flybase.bio.indiana.edu.  Null alleles 
used: ∆dpn2 (Df(2R)dpn-2) (Barbash and Cline, 1995), groE48 (Jennings et al., 2006), 
Df(3R)E(spl)P11, E(spl)-, HLHmγ-, HLHmβ-, HLHm3-, HLHm5-, HLHm7-, HLHm8- 
(Nagel et al., 2004), and Df(2L)Exel6042, Side-.  The P(Bac) insertion allele heyf06656 is 
homozygous lethal but may retain partial function.  Hey is located at position 44A2 on 
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chromosome 2R.  The FRT42B Heyf06656 chromosome was made by selecting 
P{FRT(whs)}G13 L+ recombinant progeny of + PBac{w+mC}Heyf06656 +/ 
P{FRT(whs)}G13 + L females and screening for rare flies with slightly darker eye color 
than the P{FRT(whs)}G13 parent.  Darkest eyed flies were confirmed to carry 
P{FRT(whs)}G13 PBac{w+mC}Heyf06656.  Germline clones (Chou and Perrimon, 1996) 
were generated following heat treatment of female larvae of the following genotypes:  
P{hsFLP}1, y1 w1118/ w1118 ; P{neoFRT}82B ry506 groE48/P{neoFRT}82B P{ovoD1-
18}3R and P{hsFLP}1, y1 w1118/ w1118 ; P{neoFRT}82B Df(3R)E(spl)P11/P{neoFRT}82B 
P{ovoD1-18}3R and P{hsFLP}12, y1 w/y w1118; P{FRT(whs)}G13 hey/P{FRT(whs)}G13 
P{ovoD1-18}2R.  Females bearing recombinant germlines were crossed to w1118/Y males 
and their gromat- or heymat- progeny analyzed.  The hb-hairy-en transgene (Jimenez et al., 
1997) was generously provided by G. Jimenez (IBMB-CSIC-PCB, Barcelona), dpn 
alleles were from T. Cline (University of California, Berkeley), E(spl)P11 was a gift of 
A. Preiss (University of Hohenheim), FRT82B groE48 was provided by P. Simpson 
(University of Cambridge).  Other fly stocks, including those used for FLP/FRT 
recombination, were provided by the Bloomington Drosophila stock center: #13509 y1; 
P{SUPor-P}BgbKG03779 ry506/TM3, Sb1 Ser1; #11298  P{P-Sal}dmP0/C(1)DX, y1 
f1; bw1; st1. 
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3. MATERNAL GROUCHO AND BHLH REPRESSORS AMPLIFY THE DOSE-
SENSITIVE X CHROMOSOME SIGNAL IN DROSOPHILA SEX 
DETERMINATION*  
 
My contribution to this section was to show that corepressor Gro is a potent 
negative regulator of SxlPe. I also identified that Gro has a stronger and earlier effect on 
SxlPe then does dpn, and I identified maternal Hey as a negative regulator of SxlPe. 
Dpn binds canonical and non-canonical sites at SxlPe 
To identify Dpn-binding sites at SxlPe we expressed and a full length Dpn-
maltose-binding protein fusion and used the pure MBP-Dpn to DNase I footprint the 1.4 
kb region of SxlPe sufficient to confer high-level female-specific expression (Estes et 
al., 1995). We found three protected regions in the proximal 400 bp of SxlPe (Fig. 1A).  
One region was centered on the two canonical Dpn-binding sites located at -110 and -
121 bp (Hoshijima et al., 1995; Winston et al., 1999).  The other protected regions were 
centered at -160 and -330 bp where no sequences match identified HES protein-binding 
sites (Fig. 2) suggesting that Dpn, like the bHLH activator Sc/Da (Yang et al., 2001), 
binds non-canonical sites at SxlPe.  
To identify the non-canonical sequences mediating Dpn binding, we carried out  
___________ 
*Reprinted from Developmental Biology 323(2), Lu H, Kozhina E, Mahadevaraju S, Yang D, Avila 
FW, Erickson JW, Maternal Groucho and bHLH repressors amplify the dose-sensitive X chromosome 
signal in Drosophila sex determination, 248-260, Copyright © 2008, with permission from Elsevier 
Inc.  
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of a series of gel-mobility shift assays using a purified 6X His-tagged Dpn bHLH 
domain fusion protein.  Oligonucleotides containing the previously characterized tandem 
sites 1 and 2 produced two gel-shifted complexes corresponding to dimeric and 
tetrameric  
 
 
 
Fig. 1.  Binding of Dpn to canonical and non-canonical DNA sequences at SxlPe.  A) 
DNase I footprinting with the indicated units of full-length MBP-Dpn fusion protein.  
One unit equaled 0.3 pmole (15 nM) MBP-Dpn.  Left panel, protection of Dpn-binding 
site 4, right panel, protection of Dpn-binding sites 1, 2, and 3.  Six bp core sequences are 
indicated.  Probes extended from -204 to -373 (left) and -229 to +72 (right).  Protection 
of Dpn-binding site 3 is also visible in Fig. 6 of Hoshijima et al., (1995).  B) 
Electrophoretic mobility-shift assays (EMSA).  Indicated units of GST-Dpn bHLH 
fusion protein were incubated with 32P-labeled oligonucleotides and the complexes 
resolved on polyacrylamide gels.  One unit equaled 0.3 pmole (15 nM) GST-Dpn bHLH 
protein. Core sequences for the Dpn-sites are shown.  C) Binding site competition in 
EMSA.  Complexes were formed between GST-Dpn bHLH protein (0.02 units) and a 
32P-labeled site (1+2) probe and challenged with 10- to 160-fold molar excesses of 
oligonucleotides (1+2), 3, or 4 as competitors. 
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sequences eliminated Dpn binding (Fig. 1B).  Consistent with the quantitative Dpn:DNA 
complexes (Winston et al., 1999) and mutations in the site 1 and 2 core study of 
(Winston et al., 1999), we found no evidence for cooperative binding to tandem sites 1 
and 2 by the Dpn bHLH domain.  To determine the sequences of Dpn-binding sites 3 
and 4, we examined a series of overlapping oligonucleotides for their ability to bind the 
Dpn bHLH domain.  We found that Dpn bound to oligonucleotides 3 and 3C containing 
the sequence CACACT but not to the similar fragment 3Cm carrying the single base 
change CACcCT (Fig. 1B).  Similarly, we found that Dpn bound to oligos 4 and 4C but 
not to 4L or 4R suggesting that the central CACGTT sequence is the core sequence for 
Dpn site 4.  Consistent with this inference, mutations that changed the sequence to 
CAaGcT prevented Dpn binding in the gel-shift assay (Fig. 1C).  The distal portion of 
SxlPe has a second CACGTT sequence at -1006.  We found that the Dpn bHLH protein 
bound an oligonucleotide containing this distal site further supporting our conclusion 
that CACGTT is a Dpn-binding site.  The distal site 5 was likely missed in our 
footprinting assays because it was too close to the ends of the probes.  
The three different core sequences exhibited a range of Dpn-binding affinities in 
the DNase I protection experiments.  Consensus sites 1 and 2 were always protected at 
lower Dpn concentrations than was site 3.  Dpn-binding site 3 in turn, was protected by 
lower Dpn concentrations than was site 4 suggesting that the overall binding affinities 
are sites 1, 2 > 3 > 4.  To further test the relative binding affinities of the Dpn sites, we 
performed DNA binding competition experiments.  We found that Dpn could be 
competed off the tandem consensus sites 1 and 2 by oligonucleotides containing single 
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sites 1, 3, or 4, but not by a mutant site 1 sequence (Fig. 1C and unpublished data).  
Based on the footprinting and gel-shift data we estimate that Dpn-binding sites 1 and 2 
are bound with approximately four-fold greater affinity than is site 3, which in turn is 
bound two to five times more tightly than site 4 (Fig. 1 and unpublished data).  Binding 
to the non-canonical site 3 and site 4 sequences is not specific to Dpn, because the 
related protein Side (CG10446) bound the same sequences with similar relative affinities 
(unpublished data). 
 
 
Fig. 2.  Location of protein-binding sites at SxlPe.  Diagram represents sequences from -
t al. 
d 
 + 
In vitro defined Dpn sites bind HES proteins in vivo  
We employed three assays to determine whether the Dpn-binding sites we 
identified in vitro can be recognized by Dpn or related HES proteins in vivo.  First, we 
asked whether Dpn could bind artificial promoters carrying multimers of the predicted 
Dpn-binding sites in cultured cells.  Next, we asked if ectopic hairy protein could bind 
1.1 kb to +1 relative to start of transcription.  Triange apices denote positions of 
identified protein-binding sites.  Ten binding sites for the activator Sc/Da (Yang e
2001) and two binding sites for the activator STAT (Avila and Erickson 2007) are 
shown above the line.  The five HES-class repressor-binding sites are numbered an
shown below the line.  Core HES-binding sequences are capitalized.  Sequences from
42 to - 392 are sufficient for sex-specific expression of SxlPe but sequences to -1.4 kb 
are needed for near wild-type expression (Estes et al. 1995). 
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the predicted sites in embryos, and finally, we asked whether the predicted Dpn-binding 
sites mediated repression of SxlPe-lacZ reporters in otherwise normal embryos. 
To analyze Dpn binding in Schneider L2 cells, we created an activator form of 
Dpn containing the Dpn bHLH domain fused to the VP16 activation domain (Jimenez et 
al., 1999) and assayed for the ability of Dpn-VP16 to activate transcription from 
promoters carrying four tandem copies of the predicted Dpn-binding sites (Fig. 3A).  
When Dpn-VP16 was expressed from the Actin5C promoter it stimulated transcription  
 
 
 
 
Fig. 3.  Canonical and non-canonical DNA sequences mediate HES protein-binding at 
SxlPe.  (A) Dpn-VP16 activates transcription in SL-2 cells via predicted Dpn-binding 
site 1, 2, 3, and 4 sequences.   Four copies of Dpn-binding sequences were joined to a -
95bp SxlPe-luciferase reporter and co-transfected with an actin5C promoter-Dpn-VP16 
expression vector.  Data are expressed as luciferase activity with actin-Dpn-VP16 
relative to the actin5C promoter control (+/- one standard deviation).  (B) Repression of 
SxlPe-lacZ by anteriorly-expressed hairy-engrailed (hb-h-en).  In situ hybridizations 
detect SxlPe-lacZ mRNA in embryos carrying wild-type (wt) or mutant (1-2-, 3-4-, 1-2-3-
4-) Dpn-binding sites.   Female embryos shown, Dpn-site mutant transgenes responded 
similarly to hb-h-en in males.  (C) Ectopic expression of SxlPe-lacZ transgenes carrying 
Dpn-binding site mutations.  In situ hybridizations to detect lacZ mRNA.  All embryos 
carry two copies of the indicated SxlPe-lacZ transgenes inserted on an autosome. 
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from a luciferase reporter plasmid carrying four copies of the canonical CACGCG core 
sequence upstream of the otherwise inactive minimal SxlPe promoter.  Plasmids 
carrying four copies of the site 3 CACACT or site 4 CACGTT core sequences supported 
levels of Dpn-VP16 activated transcription nearly equivalent to those seen with  
consensus sites.  Point mutations in sites 3 and 4 blocked activation, confirming that 
 
 
Table 1.  Summary of expression of 1.4 kb SxlPe-lacZ transgene lines. 
Abreviations: wt, wild-type 1.4 kb SxlPe-lacZ; 1-, 2 -, 3 -, 4 -, Dpn-binding site mutations 
in 1.4 kb SxlPe-lacZ.  Genotypes are normal + or deficient for maternal gromat- or 
zygotic Δdpn2.  XY male, XX female chromosome complement. 
 
SxlPe-
lacZ 
Embryo 
genotype 
Onset lacZ expression (# 
transgene lines) 
Comments 
wt +/+ XY cycle 13 (3) XX cycle 11 (3) 
XY: occasional nuclei express cycles 13-14. No detectable 
mRNA.  XX: some nuclei express cycle 11.  Trace mRNA 
cycle 13, strong mRNA cycle 14. 
wt gromat- XY (1) XX (1) 
XY: many nuclei express cycle 12.  Strong mRNA cycles 
13-14.  XX: some nuclei express cycle 10, all in cycle 11.  
Strong mRNA cycles 13, 14. 
wt ∆dpn2 XY cycle 13 (1) XX cycle 11 (1) 
XY: many nuclei express cycles 13, 14.  Moderate mRNA 
accumulation cycle 13-14.  XX: like +/+ genotype. 
1- +/+ XY cycle 13 (3) XX cycle 11 (3) 
XY: most nuclei express cycles 13-14.  Relatively uniform 
mRNA cycle 14.  XX: nearly all nuclei express cycle 11.  
mRNA visible cycle 13, strong in 14. 
2- +/+ XY cycle 12 (3) XX cycle 10 (3) 
XY: some nuclei express cycle 12, many cycle 13. 
Moderate mRNA cycle 13, strong mRNA cycle 14, lower 
than 1-.  XX: Some nuclei express cycle 10, many to all, 
cycle 11. Strong mRNA cycles 13-14, lower than 1-. 
3- +/+ XY cycles 12 (2) 13 (2) XX cycle 11 (4) 
XY, XX: like wt SxlPe-lacZ in ∆dpn2 genotype. 
4- +/+ XY cycle 13 (2) XX cycle 11 (2) 
XY, XX: indistinguishable from wt transgenes in +/+ 
genotype. 
1-2- +/+ XY cycle 12 (2) XX cycles 10 (2) 
XY, XX: nuclei like 2-. mRNA like 1- but elevated. 
3-4- +/+ XY cycle 12 (3) XX cycle 11 (3) 
XY, XX: indistinguishable from 3- transgenes. 
1-2-3-4- +/+ XY cycle 12 (3) XX cycle 10 (3) 
XY: many nuclei express cycle 12.  Strong mRNA cycles 
13-14. XX: some nuclei express cycle 10, almost all by 
cycle 11.  Strong mRNA cycles 13-14. 
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these non-canonical sequences can mediate Dpn-binding in cultured cells.  
To determine if the Dpn-binding sites can mediate HES protein-binding and 
transcriptional repression in embryos, we created a series of transgenic 1.4 SxlPe-lacZ 
reporters carrying mutations in the predicted Dpn-binding sites and assayed their effects 
in vivo.  We first asked if the reporters could mediate repression by an ectopically 
expressed version of Hairy that carries the Gro-interacting repression domain from the 
engrailed protein (Jimenez et al., 1999).  In this assay, first employed on endogenous Sxl 
(Parkhurst et al., 1990), zygotic expression of Hairy-Engrailed from the anteriorly-
expressed hunchback promoter causes anterior-specific repression of target genes 
carrying HES protein-binding sites.  We found that Hairy-En repressed SxlPe-lacZ even 
when both canonical Dpn-binding sites 1 and 2 were mutated (1-2-) although the degree 
of repression was less than seen with wild-type SxlPe-lacZ fusions (Fig. 3B).  These 
findings indicate that Dpn-binding sites 1 and 2 bind Hairy-En, but also suggest that 
other, non-canonical, sequences can mediate Hairy DNA-binding in vivo.  Those non-
canonical sites appear to be at least one of Dpn-binding sites 3 and 4, because the (3-4-) 
SxlPe-lacZ transgenes were also less effectively repressed by Hairy-En than was wild-
type SxlPe-lacZ, and because mutations in all four Dpn-binding sites (1-2-3-4-) 
eliminated nearly all Hairy-En mediated repression (Fig. 3B).  
As a third test of the functions of the predicted Dpn-binding sites, we asked 
whether mutations affecting individual or multiple sites increased expression from 
SxlPe-lacZ transgenes, as would be expected if the sites normally mediate repression by 
Dpn or other HES proteins.  We focused on male embryos because they do not express 
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detectable cytoplasmic lacZ mRNA from wild-type SxlPe-lacZ transgenes (Estes et al., 
1995; Bosch et al., 2006; Avila and Erickson, 2007).  We found that mutations affecting 
Dpn-binding sites 1, 2, or 3, led to ectopic SxlPe-lacZ expression in male embryos (Fig. 
3C), confirming that these three sites mediate repressor-binding at SxlPe.   A Dpn-
binding site 4 mutation, in contrast, did not cause ectopic SxlPe-lacZ expression in males 
(Table 1), suggesting that the weakest in vitro Dpn-binding sites may not mediate 
repression in vivo.  In the following sections we explore the function of Dpn-binding 
sites 1, 2, and 3 in relation to the actions of Dpn and other HES proteins, as well as those 
of the corepressor, Gro, in the sex-specific regulation of SxlPe. 
The corepressor Gro is a potent negative regulator of SxlPe 
Maternally supplied Gro interacts with several different types of DNA-binding 
proteins, including Hairy and Dpn, to repress transcription in the early embryo (Jimenez 
et al., 1997; Fisher and Caudy, 1998a; Chen and Courey, 2000; Buscarlet and Stifani, 
2007).  Paroush et al., (1994) identified gro as a negative regulator of Sxl, reporting that 
loss of maternal gro function caused strong ectopic activation of Sxl in males that 
rendered male and female embryos indistinguishable with respect to Sxl protein levels. 
Because equality of Sxl expression between the sexes would have important 
implicationsfor the mechanism of X chromosome counting, as well as for maintenance 
expression of this X-linked regulator of dosage compensation, we examined the effects 
of maternal gro on both SxlPe activity and on Sxl protein levels.  Staining with anti-Sxl 
antibody confirmed that XY embryos derived from mothers with groE48 germline clones 
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Fig. 4.  Sxl protein in gromat- embryos.  Embryos from mothers bearing groE48 germline 
clones were immunostained stained for Sxl.  Embryonic stages are mid-cellularization 
(left) and gastrulation (right).  (Top panels) XX and XY embryos bearing normal doses 
of the X-linked Sxl gene.  (Bottom panels) XX and XY embryos each with one 
functional copy of Sxl+ were the progeny of females with FRT82B groE48 germ cells and 
y w cm Sxlf1 ct/Y males. 
 
 
 
 (hereafter gromat-), express Sxl protein in most or all cells, but also revealed, contrary to 
the initial report, that Sxl levels were higher in XX than in XY embryos at all stages 
(Fig. 4).  The observed sex differences in Sxl staining could not be accounted for by 
gene copy number as Sxlf1/Sxl+ females carrying only one functional Sxl allele still 
stained more darkly than their Sxl+/Y brothers (Fig. 4).  We found similar effects on 
SxlPe-derived mRNA, with females always staining more intensely than males (Fig. 5), 
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demonstrating that Sxl retains some ability to differentiate between male or female XSE 
gene doses in the absence of maternal gro.  
Gro has a stronger and earlier effect on SxlPe than does dpn 
Loss of maternal gro raises ectopic male Sxl protein levels well above those 
present in dpn mutants (Younger-Shepherd et al., 1992; Paroush et al., 1994; Barbash 
and Cline, 1995; Fig. 4 and unpublished data).  To understand the differential effects of 
gro and dpn on Sxl transcription, we asked how elimination of maternal gro and zygotic 
dpn functions altered the timing of SxlPe activation and the levels of mRNA using in 
situ hybridization to measure nascent and mature Sxl transcripts (Fig. 5).  
 In wild-type XX embryos, SxlPe is expressed from nuclear cycle 12 through the 
first minutes of cycle 14 (Barbash and Cline, 1995; Avila and Erickson, 2007; Erickson 
and Quintero, 2007).  In normal XY embryos the promoter remains silent.  We observed 
that the ∆dpn2 deletion had no detectable effect on SxlPe activity in XX embryos, but 
that the dpn deletion caused sporadic and weak ectopic Sxl expression in XY embryos 
beginning in cycle 13 (Fig. 5; Barbash and Cline, 1995).  During early cycle 14, SxlPe 
became active in more XY nuclei, but this caused only a modest and non-uniform 
accumulation of SxlPe-derived mRNA, consistent with the low-level accumulation of 
ectopic SXL (Barbash and Cline, 1995).   
In contrast, loss of maternal gro function caused earlier, stronger, and more 
uniform effects on SxlPe than did deletion of dpn (Fig. 5, Table 1).  We observed ectopic 
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Fig. 5. Time course of SxlPe activation in wild-type, Δdpn2, and maternal groE48 mutant 
embryos. Wild-type and mutant embryos were stained following in situ hybridization. 
Black and white panels show surface views of embryonic nuclei at indicated nuclear 
cycles. Dots represent nascent transcripts from the X-linked Sxl locus. Cycle 12 nuclei 
were illuminated with UV and visible light to enhance DAPI-stained nuclei. Color 
panels show peak accumulation of SxlPe-derived mRNA in early cycle 14. Embryos 
were progeny of wild-type (wt, w1118) females and males, w1118; Δdpn2/CyO females and 
males, or females with FRT82B groE48 germ lines and w1118/Y males. Cycle 12 embryos 
from Δdpn2/crosses could not be distinguished from Δdpn2 heterozygotes or wildtype of 
the same sex. Time courses are representative of repeated stainings of embryos from 
four separate inductions of groE48germline clones and five series of embryo collections 
from crosses between Δdpn2 heterozygotes. 
 
 
 
 Sxl expression in many nuclei in cycle 11 XX embryos and in occasional nuclei 
in cycle 12 XY embryos.  Every XX gromat- nucleus expressed SxlPe throughout cycle 
12, and every XY nucleus expressed SxlPe by the end of cycle 13.  As a consequence, 
Sxl mRNA was present at relatively low, but uniform, levels in XY embryos and at 
slightly elevated levels in XX females.  Nacent SxlPe transcripts were detected until 
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about 15 min into cycle 14 in both sexes suggesting that maternal gro does not 
significantly affect the timing of the shut-off of SxlPe. 
 The finding that maternal gro has stronger and earlier effects on SxlPe than does 
dpn could be explained in several ways:  by the involvement of additional HES-related 
proteins, by the involvement of yet other types of Gro-interacting proteins, or by indirect 
effects of the pleiotropic gro gene in the germline or early zygote.  One way to 
distinguish between these possibilities is to ask what effects mutations in the Dpn-
binding sites have on SxlPe activity.  If Dpn is the only HES-type repressor to regulate 
SxlPe, or if Gro acts indirectly, then the effects of mutations in the Dpn-binding sites 
should equal those of dpn null alleles.  On the other hand, if additional HES proteins 
repress SxlPe, the cis-acting changes should exert a stronger effect than dpn mutations 
because they would block the actions of all repressors utilizing those DNA-binding sites.  
Dpn-binding site mutations affect SxlPe more than the loss of Dpn protein 
 Comparison of the male embryos carrying Dpn-site mutant SxlPe-lacZ reporters 
shown in Fig. 3C with the ectopic expression of endogenous Sxl in the Δdpn2 male in 
Fig. 5 immediately suggests that the cis-acting binding site mutations have stronger 
effects on SxlPe than does loss of dpn.  However, this simple comparison is potentially 
misleading because wild-type 1.4 kb SxlPe-lacZ transgenes do not precisely mimic the 
normal promoter.  Specifically, wild-type SxlPe-lacZ transgenes exhibit low-level 
activation in XY embryos and are expressed earlier in XX embryos than is endogenous 
SxlPe (Bosch et al., 2006) Table 1).  To determine if the relatively strong lacZ 
expression from the Dpn-binding site mutant transgenes implicated other bHLH 
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repressors in Sxl regulation, or if it was instead caused by the loss of Dpn-binding to 
already derepressed transgenes, we compared the effects of the Δdpn2 mutation on 
SxlPe-lacZ expression with those of the Dpn-binding site mutations.  We found, that 
while Δdpn2 elevated SxlPe-lacZ reporter expression more than the endogenous Sxl 
locus, the effects of most Dpn-binding site mutations were stronger still.  The 1-, 2-, 1-2,- 
and 1-2-3-4- Dpn-site mutations caused SxlPe-lacZ to be expressed in more nuclei at 
earlier times and at higher overall levels than did Δdpn2 (Table 1).  Transgenes carrying 
Dpn-binding site 3- and 3-4- mutations expressed ectopic lacZ at levels and times similar 
to the wild-type SxlPe-lacZ reporter in Δdpn2 mutants.  This could indicate that Dpn 
binds only to site 3, but we favor the simpler idea that this non-canonical sequence is 
less effective at mediating repression than are sites 1 and 2. 
A search for other bHLH repressors of SxlPe 
 Our findings that mutations in the cis-acting Dpn-binding sites led to earlier and 
higher levels of SxlPe-lacZ expression than did loss of dpn protein, suggests that other 
bHLH proteins bind these sequences to repress SxlPe.  We used a genetic approach to 
identify the missing proteins by examining mutants with defects in known, or predicted, 
bHLH repressors for alterations in SxlPe expression (Moore et al., 2000; Ledent and 
Vervoort, 2001).   
We began with E(spl)m3, a maternally supplied HES-family repressor previously 
cited as a negative regulator of SxlPe (Dawson et al., 1995; Poortinga et al., 1998).  We 
found that embryos derived from mothers whose germlines lacked E(spl)m3, expressed 
SxlPe in a completely wild-type pattern (data not shown).  There was no ectopic 
 23
activation of SxlPe in XY embryos, and XX embryos expressed SxlPe at normal levels 
with normal timing.  Homozygous mutant embryos were also wild-type for Sxl 
expression indicating that any zygotically expressed E(spl)m3 was without effect on 
SxlPe.  The deletion allele we used, Df(3R)E(spl)P11, also removes the E(spl), E(spl)mγ, 
E(spl)mβ, E(spl)m5, E(spl)m7, and E(spl)m8 loci (Nagel et al., 2004), eliminating seven 
HES proteins as maternal or zygotic regulators of SxlPe.  The protein most similar to 
Dpn is Side (CG10446) (Moore et al., 2000).  We examined several Side deletion 
mutants for dominant maternal and recessive zygotic effects on SxlPe, but found none, 
consistent with reports that Side is not expressed maternally, or in the early embryo 
(Tomancak et al., 2002; Chintapalli et al., 2007; but see Moore et al., 2000).  We did not 
analyze Side for recessive maternal effects because we expected the relatively large Side 
deletions to be cell lethal in germline clones. 
Maternal Hey negatively regulates SxlPe 
The Hey gene encodes a protein related to Dpn, Hairy, and E(spl), but which 
lacks the characteristic C-terminal Gro-binding WRPW motif (Kokubo et al., 1999; 
Leimeister et al., 1999).  Instead, Hey and its mammalian homologs posses a YRPW 
motif that appears not to interact with Gro/TLE proteins (Davis and Turner, 2001; Iso et 
al., 2001; Fischer and Gessler, 2007; Kageyama et al., 2007).  Nonetheless, Hey proteins 
can potentially interact with Gro as they form heterodimers with several different HES 
proteins, including Dpn (Iso et al., 2001; Giot et al., 2003; Chintapalli et al., 2007).  The 
resulting Hey/HES heterodimers appear to bind DNA with higher affinity than the 
individual homodimers (Iso et al., 2001).  The single available mutation, Heyf06656, is a  
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Fig. 6.  Maternal Hey negatively regulates SxlPe.  Surface views of embryos at indicated 
nuclear cycles stained after in situ hybridization to detect nascent transcripts from the X-
linked SxlPe.  Top row: wild-type XX embryos.  Middle and bottom rows: XX and XY 
progeny of mothers carrying Heyf06656 germline clones (Heymat-).  Wild-type XY 
embryos do not activate SxlPe. 
 
 
 
recessive lethal caused by a P(Bac) insertion in the 1st intron.  To examine the effects of 
Hey on SxlPe, we recombined Heyf06656 onto an FRT-containing chromosome and 
generated Heyf06656 germline clones (Chou and Perrimon, 1996).  We found that 100% of 
Heymat- XY progeny expressed SxlPe ectopically during cycles 13 and 14 but that Sxl 
expression was spatially variable, with about half the nuclei in each XY embryo 
expressing SxlPe (Fig. 6).  There was no observable accumulation of Sxl mRNA in XY 
embryos, consistent with the lack of a dominant maternal effect on male viability.  SxlPe 
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activity also appeared to be affected in XX Heymat- progeny as we noticed an increase in 
the proportion of cycle 12 XX embryos that expressed SxlPe, and an increase in the 
proportion of active nuclei in the expressing embryos (Fig. 6, see Materials and 
Methods).  
 The identification of Hey as a maternally-supplied bHLH repressor of SxlPe, 
fulfills an important prediction of our experiments: that bHLH repressors in addition to 
Dpn regulate the on-or-off control of SxlPe.  The involvement of maternal Hey and gro 
are also in keeping with the hypothesis that maternal repressors are integrated parts of 
the mechanism by which XSE concentrations, rather than X:A ratios, are sensed in the 
embryo (Cline, 1993; Erickson and Cline, 1993; Barbash and Cline, 1995, Wrischnik et 
al., 2003; Erickson and Quintero, 2007).  Whether the relatively weak effects of 
Heyf06656 are explained by partial Hey protein function, or whether yet other HES family 
repressors regulate SxlPe remains to be determined. 
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4. CLOCKWORK ORANGE AND MYC ARE ADDITIONAL REPRESSORS OF 
SXL 
 
Clockwork orange is a transcription factor that represses expression of SxlPe  
Clockwork orange (CG 17100) is a bHLH transcription factor most closely 
related to the Gridlock and E(spl)-hairy families.  In flies, these families include Hey, 
cwo, hairy, deadpan, E(spl) complex, Side and CG5927 (Ledent et al., 2001).  
Clockwork orange (cwo) lacks the tetrapeptide WRPW present in most of these proteins 
and is responsible for interaction with corepressor Gro.  
  Despite the absence of WRPW Gro - interacting domains, cwo is thought to be a 
transcriptional repressor (Matsumoto et al., 2007).  It recognizes “type B” E box 
CACGTG (Matsumotoet al., 2007), two of which are present at 3220 bp downstream 
from ATG site of SxlPe promoter.  It is possible that cwo regulates Sxl not from these 
but other noncanonical E-boxes including Dpn binding sites. 
Expression of SxlPe in cwo mutants begins 2 cycles earlier than in wild-type 
To determine if cwo regulates Sxl expression, we examined nascent RNA 
transcripts from SxlPe in the homozygous viable cwof05073 mutant. cwof05073 is a 
PBac{WH} insertion into the first intron of cwo gene.  
Expression of SxlPe in cwof05073 mutant began 2 cycles earlier than in wild-type (Table 
2).  In wild-type, embryo expression begins in cycle 12.  This data implies that cwo acts 
as a transcriptional repressor of Sxl and, in the cwo mutant, we observed derepression of 
the Sxl promoter.  It is not possible to determine from our data if it is the maternal or 
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zygotic contribution of cwo that negatively regulates Sxl.  Published data do not include 
cwo among the earliest zygotic genes, other data against its early zygotic expression is  
 
 
Table 2. Expression of SxlPe in cwof05073 mutant.  Nuclei from each embryo were scored 
as expressed or not expressed Sxl (columns “expression”): the first number is the number 
of nuclei that expressed Sxl; the second number is the overall number of counted nuclei.  
Nuclei that expressed in one dot (from one X chromosome) and two dots (from two X 
chromosomes) were counted. Columns “expression in one dot”: the first number is the 
number of nuclei that expressed Sxl in one dot; the second number is the overall number 
of nuclei that expressed Sxl.  The next column is a graphic representation of column 
“expression”. 
 
Cycle Expression   Expression in one
dot      
 Fraction of nuclei 
that express Sxl in
each embtyo 
Cycle 9     (All embryos are at
mitosis)                    
  
    
Cycle 10   11/30 10/11     IIIIIII 
  0/30 0           
Cycle 11       25/41 8/25    IIIIIIIIIIII 
 15/35 15/15     IIIIIIII 
 15/42 15/15      IIIIIII 
 3/33 3/3     II 
Cycle 12             19/20 10/19     IIIIIIIIIIIIIIIIIIIII 
 21/21 6/21       IIIIIIIIIIIIIIIIIIIIII 
 27/27 12/27      IIIIIIIIIIIIIIIIIIIIII 
 27/27        2/27        IIIIIIIIIIIIIIIIIIIIII 
 21/50        2/21         IIIIIIII 
 13/24        13/13        IIIIIIIIIII 
 15/25         15/15         IIIIIIIIIIII 
 9/27         9/9        IIIIII 
 7/41           7/7           IIII 
 0/37           0            
 0/20           0             
 1/37           1/1           I 
 0/40          0             
 
 
 
the absence of TAGteam motif in its promoter region (Erickson and Cline, 1998).  So, 
most probably, it acts as maternal gene. 
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 Ectopic expression in males and earlier expression at a higher level in female 
embryos at cycle 11 support our hypothesis about repressor function of cwo during the 
earliest stages of development. 
Expression at cycle 12 also supports our hypothesis about the repressive function 
of cwo on SxlPe. I observed embryos that expressed Sxl from only one X chromosome. 
Nevertheless, it is not enough data to conclude entopic expression in male embryos at 
cycle 12. Embryos that are expressed in one dot can be as male as female embryos that 
expressed only from one out of two X chromosomes.  Most likely cwo is more important 
as a Sxl repressor at the earlier stages of development. At cycle 12, other repressor(s) can 
play a more significant role at Sxl repression. Sxl stayed repressed at cycle 12 in 
presumably male embryos (#10-#13, Table 2) even without (or at a significantly reduced 
level of) Cwo protein in the homozygous mutant.   
Complex mechanism allows maintaining repressed status of Sxl in wild-type 
males and activation in females during 40 min at cycle 12 – early 14.  At the beginning 
of each cycle (telophase phase of mitosis), expression was repressed in all nuclei in 
female as well as in male embryos (data not shown).  Then expression reactivated in 
females but stayed repressed in males. A very similar mode of telophase repression can  
be observed at cycles 12, 13 and 14.  Although repression at early cycle 14 is not 
absolutely completed or very short, cwo repression may prevent activation in early male 
embryos in the beginning of each cycle. Later other repressors may play this role. 
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Fig. 7. Cwo represses SxlPe in early embryos. SxlPe is expressed approximately 20 min 
or 2 cycles earlier in homozygous cwof05073 mutants.   
Mutant cwof05073 embryos were stained following in situ hybridization.  Black and 
white panels show surface views of embryonic nuclei at indicated nuclei cycles.  Dots 
represent nascent transcripts from the X-linked Sxl locus.  Color panels show peak 
accumulation of SxlPe-derived mRNA in early cycle 14.  Embryos are homozygous 
cwof05073 mutants  
 
 
 
There is no difference in the level of mRNA cytoplasmic accumulation of SxlPe in 
cwo mutants 
Expression at cycle 13 and cycle 14 in cwo mutant was indistinguishable from 
wild-type expression.  There was also no difference in the level of mRNA cytoplasmic 
accumulation of Sxl (Fig. 7).  This observation supports our hypothesis about cwo 
repressing specifically at the earliest stages of development.  
Expression of Sxl protein was not very different from wild-type embryos.  Half 
embryos (females) expressed Sxl.  Fifteen of the 486 embryos had abnormal patterns of 
Sxl expression.  Most of them (10 out of 15) looked like morphologically normal 
embryos in the germband elongation stage with either very low levels of Sxl 
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Fig. 8.  Sxl level are normal: cwo mutant, but occasional embryos display abnormal 
staining patterns.  Two different homozygous mutant cwof05073 and cwoe04207  
express Sxl mostly in the central and posterior part of the embryos in germline 
elongation stage. Arrows point expression in more posterior half of the embryos. 
 
 
 
expression or expression localized only in the central and posterior part of the embryo 
(Fig. 8).  All the other female embryos expressed Sxl at normal levels.  Another 
homozygous viable cwo mutant cwoe04207 had a similar pattern of Sxl expression.  In this 
mutant, 6 out of 118 counted female embryos had abnormal patterns of Sxl expression 
(Fig. 8) but all but one of these 6 embryos were also morphologically abnormal.   
The male/female ratio of the adult flies is close to 1:1 (58 females to 73 males from 131 
counted adult flies).  So cwo can be one of the regulators of Sxl expression only on the 
early stages of development. 
Myc is a maternal repressor of Sxl 
 
Myc is a bHLH-leucine zipper activator transcription factor that binds “class B” 
E-box sequences CA(C/T)GTG (Fisher and Caudy,1998b; Dang et al., 1992).  It also can 
bind non-canonical CA(C/T)GCG, CACGAG, CACGTTG sites (Yang et al.,2001; 
Blackwell et al., 1993). Myc DNA binding requires the cofactor Max.  Max can also 
bind to the related Mnt protein to form a repressor complex. Myc regulates cell growth 
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by controling ribosome biogenesis and controls the progression through the G1 phase of 
the cell cycle (Grandori et al., 2000, De la Cova and Johnston, 2006).  In Drosophila, 
Myc is supplied maternally to the embryo (Gallant et al., 1996). 
The SxlPe promoter contains 2 non-canonical sequences CA(C/T)GCG for Myc 
protein that also function as Dpn binding sites (Lu et al., 2008). 
To determine if Myc regulates Sxl expression, we examined nascent transcripts 
from SxlPe in the progeny of mothers heterozygous for the weak Myc dm1, dmP0 
mutants, and strong dmP1 mutant.  It is not possible to induce homozygous dm germline 
clones because Myc is essential for oogenesis.  The dm1 allele is a gypsy insertion into 
the first intron, 418 nucleotides upstream of the translation initiation site.  dmP0 is caused 
by the insertion P{P-Sal}dmP0, which is less than 100 bp upstream of putative 
transcription start site; dmP1 is caused by insertion in the same place P{P-Sal- P1}dmP1, 
which is internal deletion of P{P-Sal} element. Mutation dmP1 is considered to be the 
strongest mutation. 
Expression of SxlPe in Myc mutants begins 2 cycles earlier than in wild-type 
I investigated expression of SxlPe in Myc mutant embryos that were progeny 
from the cross dmP1/FM7 x dmP1/Y.  Female embryos from this cross have genotype 
either dmP1/dmP1 or dmP1/FM7 and male embryos have genotype dmP1/Y or FM7/Y.  All 
embryos have heterozygous dm P1/FM7 mothers.   
I did not observe any entopic SxlPe expression at cycle 8 (approximately 80 min 
after fertilization) and only very weak (possibly background) level of expression in one 
embryo at cycle 9 (Table3).  At cycle 10 I observed ectopic expression of SxlPe in most 
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or all embryos.  Early expression implies that Myc acts as a repressor for SxlPe at this 
time of development.  But there are two possible modes of action: it can be direct 
repression by occupation of Dpn-binding site or it can act indirectly. We favor the 
indirect mode because Myc usually acts as transcriptional activator presumably by 
activation of a repressor(s).  It may be sequence - specific transcription factor repressor 
of SxlPe or repressor that keeps almost all Drosophila genes silenced at early stages of 
embryo development.  It is known that during oocyte and sperm formation chromosomes 
become tightly condensed and transcriptionally silenced.  After fertilization zygotes 
keep transcriptionally silenced status for most of genes up to cycle 14.  There are some 
genes that express earlier then cycle 14.  They included SxlPe and genes for activation 
transcription factors for SxlPe.  If maternal Myc is responsible for activation of 
repressor(s) (that keep all genes silenced at early cycle of development) then mutation of 
Myc would lead to ectopic activation of zygotic SxlPe in all embryos, as mutant for Myc 
as wild-type for Myc zygotic gene. 
I observed activation in all but one embryo at cycle 10.  That one embryo 
expressed SxlPe in only one out of 24 counted nuclei and expressed only in one dot.  
This level of expression I estimated as background negative level.  Three embryos 
expressed SxlPe in approximately 10% of the nuclei, all in one dot.  They are 
presumably male embryos.  They have Myc/FM7 heterozygous mothers and Myc/Y or 
FM7/Y zygotic genotype, where the only X chromosome that expressed SxlPe comes 
from mother.  If our assumption about the function of Myc as indirect maternal activator 
of repressor is correct, then derepression in maternal dmP1/FM7 progeny leads to ectopic 
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Table 3.  Time course of SxlPe activation in dmP1 mutant embryos (cycles 9-11).  Nuclei 
from each embryo were scored as expressed or not expressed Sxl (columns 
“expression”): the first number is the number of nuclei that expressed Sxl; the second 
number is the overall number of counted nuclei.  Nuclei that express in one dot and two 
dots were counted (columns “expression in one dot”): the first number is the number of 
nuclei that expressed Sxl in one dot; the second number is the overall number of nuclei 
that expressed Sxl.  The next column is graphic representation of column “expression”. 
 
 
Cycle Expression Expression in one dot Fraction of nuclei that 
express Sxl in each 
embryo 
Cycle 8     0/20   
 0/14   
Cycle 9   0/16   
 0/23   
 0/14   
 3/34 3/3 I 
Cycle10 1/24 1/1 II 
 6/32 6/6 II 
 7/34 7/7 II 
 3/20 3/3 II 
 10/33 9/10 IIIIII 
 25/37 24/25 iiiiiiiiiiiiiiiiiiiiii 
Cycle 11                          0/24   
 0/24   
 0/22   
 0/25   
 0/20   
 3/40 3/3 II 
 10/40 10/10 III 
 21/43 21/21 IIIIIIIIII 
 15/52 15/15 IIIIIIII 
 17/42 16/17 IIIIIIII 
 14/44 13/14 IIIIIII 
 19/53 16/19 IIIIIIII 
 34/38 22/34 IIIIIIIIIIIIIIIIIIIII 
 29/49 25/29 IIIIIIIIIIIIIIIIIII 
 
 
activation in all maternally inherited X-chromosomes.  Our data fitted well into that 
hypothesis. 
Other two (presumably female) embryos expressed SxlPe in about 30% of the 
nuclei, but only some nuclei expressed in two dots that corresponded to two X 
chromosomes in females.   
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Female embryos have dmP1/FM7 heterozygous mothers and dmP1/ dmP1 
(maternal), dmP1 (maternal)/FM7, dmP1/FM7 (maternal) genotype, where “maternal” 
corresponds to maternally inherited X-chromosome.  Only one of X – chromosomes 
expressed SxlPe at that cycle of early Drosophila development.  If our assumption of 
indirect repression function of Myc is correct, then only one of X-chromosomes would 
be derepressed in progeny embryos from cross dmP1/FM7 x dmP1/Y.  As mentioned 
above, the only X chromosome in males, that are maternally inherited, derepressed in 
males.  So it is reasonable to assume that the one of two female X-chromosome that 
expresses SxlPe is also maternally inherited.  In order to prove directly which of X-
chromosome is Myc regulated (maternally inherited, paternally inherited or both), we 
plan a set of experiments in the future. 
There is a second explanation of observed data.  We hypothesize that zygotic 
Myc directly represses Sxl or activates zygotic repressor(s) of SxlPe.  If it is correct, then 
in dmP1/FM7 or dmP1/ dmP1 female embryos we expect derepression of SxlPe expression.  
In this case we would expect derepression in both X-chromosomes but our data showed 
expression in only one of two X chromosomes in females.  So our data do not support 
importance of function of synchronically expressed Myc at this cycle of development. 
At this cycle female embryos are expressed at higher level than male embryos, 
most probably because of 2 times difference in amount of activator proteins such as 
scute and sisA located on X-chromosome.  
Expression at cycle 11.  In wild-type embryos expression of SxlPe shuts down 
each cycle at telophase and very early interphase, just after mitosis.  But in wild-type 
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embryos only small portion of embryos stayed at telophase and early interphase and do 
not express Sxl.  Reestablishment of SxlPe expression at cycle 11 in dmP1 embryos 
reveal different mode of expression. Approximately half of the embryos did not 
expressed SxlPe and half expressed in 10 – 90% of the nuclei. 
Embryos that did not express SxlPe were all at very early interphase stage.  I 
have observed unproportionally large number of embryos at very early interphase stage 
in dmP1 mutants.  It is very unlikely that it is just random fluctuation of sample 
collection.  More direct explanation is based on function of Myc protein.  It is known 
that Myc plays important role in progression through G1 phase of cell cycle.  Without 
proper amount of Myc protein G1 progression is delayed.  Most probably that is why we 
have observed unproportionally large number of nuclei at very early interphase stage, 
when SxlPe (as I mentioned earlier) is not expressed.  Why did we observe this 
phenomena starting at cycle 11 but not earlier?  Does maternal/zygotic transition of Myc 
protein play role in this phenomenon?  The Drosophila cell cycle is regulated differently 
in preblastoderm and blastoderm embryos.  Is Myc regulation of cell cycle also stage-
dependent? We do not have answers to those questions yet. 
Embryos that did express SxlPe are at interphase and prophase stage of cell 
cycle. Most of the embryos at this cycle still expressed only from one of X-
chromosomes.  
Expression in cycle 12.  At cycle 12 I still could see ectopic expression in male 
(Fig. 9) embryos and only one embryo does not express SxlPe at all (Table 4 ). Some 
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female embryos expressed mostly in one dot. So early in interphase one of X 
chromosome (presumably maternally inherited) are more derepressed up to cycle 12. 
 
 
 
Fig 9. Ectopic expression of SxlPe at cycle12 in Myc mutant male embryos. Many 
female Myc mutant embryos expressed SxlPe from only one X chromosome. 
 
 
 
Expression in later interphase and prophase of Myc embryos was higher than in 
wild-type (WT) embryos.  At cycle 12 embryos were able to express Sxl earlier in 
interphase than in the previous cycle.  On the other hand, zygotic Myc may start to 
accumulate by this time and became responsible for proper progression through G1 
stage of cell cycle. 
Expression at cycle13.  At cycle 13 expression was rather similar to expression 
in wild-type embryos.  I observed very low level ectopic expression in males, almost 
undistinguishable from some background expression in WT embryos. 
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Table 4. Time course of SxlPe activation in dmP1 mutant embryos (cycles 12-13).  
Nuclei from each embryo were scored as expressed or not expressed Sxl (columns 
“expression”): the first number is the number of nuclei that expressed Sxl; the second 
number is the overall number of counted nuclei.  Nuclei that express in one dot and two 
dots were counted (columns “expression in one dot”): the first number is the number of 
nuclei that expressed Sxl in one dot; the second number is the overall number of nuclei 
that expressed Sxl.  The next column is graphic representation of column “expression”. 
 
Cycle Expression Expression in one dot Fraction of nuclei that 
express Sxl in each 
embryo 
Cycle 12   0/30   
 3/30 3/3 I 
 6/43 6/6 III 
 17/50 17/17 IIIIIII 
 18/50 18/18 IIIIIIII 
 24/42 15/24 IIIIIIIIIIIIIIII 
 27/42 23/27 IIIIIIIIIIIIIIII 
 25/32 15/25 IIIIIIIIIIIIIIIIIIIII 
 28/34 18/28 IIIIIIIIIIIIIIIIIIII 
 55/57 27/55 IIIIIIIIIIIIIIIIIIIII 
 51/53 12/51 IIIIIIIIIIIIIIIIIIIIII 
 40/41 20/40 IIIIIIIIIIIIIIIIIIIIIII 
 28/29 11/28 IIIIIIIIIIIIIIIIIIIIIII 
 47/47 5/47 IIIIIIIIIIIIIIIIIIIIIIII 
Cycle 13 8/52 8/8 I 
 0/52   
 1/52 1/1  
 1/50 1/1  
 8/56 8/8 I 
 8/72 8/8  
 2/56 2/2  
 1/52 1/1  
 1/52 1/1  
 3/52 3/3  
 0/52   
 15/60 15/15 IIIII 
 25/33 18/25 IIIIIIIIIIIIIIIIIII 
 38/39 10/38 IIIIIIIIIIIIIIIIIIIIII 
 37/40 12/37 IIIIIIIIIIIIIIIIIIIIIII 
 17/32 13/17 IIIIIIIIIIIIIIIIII 
 25/28 10/25 IIIIIIIIIIIIIIIIIIIIIII 
 56/56 4/56 IIIIIIIIIIIIIIIIIIIIIIII 
 31/41 19/31 IIIIIIIIIIIIIIIIIIIIII 
 46/54 17/46 IIIIIIIIIIIIIIIIIIIIIII 
 
In females I observed several embryos at early interphase that expressed SxlPe at 
lower level than WT embryos.  Most probably that can be explained by some delay in 
progression through G1 stage of cell cycle in heterozygous dmP1/FM7 or homozygous 
dmP1/ dmP1 mutants.  But embryos at later interphase and prophase looked absolutely 
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normal, undistinguishable from WT embryos.  So when cell cycle progresses up to mid 
interphase, Sxl accumulation became absolutely normal. 
 
 
 
Fig. 10. Very early at cycle 14 dmP1 mutant embryos do not express Sxl mRNA in the 
central part of the embryo. 
 
 
Expression at cycle 14.  At cycle 14 very rarely I observed ectopic expression in 
males in 2-3 nuclei per embryo, which is almost identical to WT background expression 
in males.  In females I observed embryos at early interphase stage that did not express 
SxlPe at all or expressed it only in the most anterior part of the embryo (Fig 10).  The 
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same pattern of expression I observed at dm1/FM7, which is another Myc mutant.  At the 
same time, I never observed absence of SxlPe expression at cycle 14 in wild-type female 
embryos.  Most probably in dmP1/ dmP1 or dmP1/ FM7 embryos I observed delay of  
progression through G1 stage of cell cycle and more embryos stall at very early 
interphase stage.  In WT embryos G1 stage lasted for a short period of time.  Only 
during this period SxlPe expression shuts down and then reestablishes at cycle 14.  Later 
at cycle 14 Sxl expression is undistinguishable from wild-type expression.  
Myc is sensitive to mutation in the known regulator of SxlPe  
In order to answer if Myc is sensitive to mutation in the known regulator of 
SxlPe, I made double mutant sisA dmP1/FM7, investigated expression SxlPe in this 
mutant and compared it with expression in each of the mutants sisA/FM7, dmP1/FM7 and 
wild-type. 
SisA is an activator of SxlPe expression and without this transcription factor 
expression is absent: 
Stock sisA/FM7 x sisA/Y produce progeny female embryos sisA/sisA, sisA/FM7 
and males sisA/Y, FM7/Y.  Expression of SxlPe in sisA/FM7 females was 
undistinguishable from wild-type and absent in sisA/sisA females.  Expression in sisA/Y 
and FM7/Y males was absent which is identical to wild-type expression in males.  
Quarter of all embryos, which is sisA/FM7, expressed SxlPe.  In double mutant sisA 
dmP1/FM7 expression reestablished in sisA dmP1/sisA dmP1females (Fig 11).  Those 
results confirmed our previous observation of repressor function of Myc protein on 
SxlPe.  I observed expression only in the middle part of the embryo. 
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Fig. 11. Myc represses SxlPe expression at early cycle 14. Restoration of SxlPe 
expression in homozygous sisA/sisA mutants with additional second mutation dmP1. 
 
 
 
These results suggest that Myc most probably takes part in sex determination in 
Drosophila. It is not a strong repressor but more sensitive approach of double mutant 
reveals its influence on SxlPe expression.  
We can conclude that: 
 
1) Myc does influence sex determination. The mode of regulation needs to be 
further investigated. 
2) Myc affects the reestablishment of SxlPe activity at the beginning of each 
interphase, perhaps by affecting the G1 stage of cell cycle progression. 
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3) Myc may provide a tool for investigating differences in expression from 
maternally and parentally inherited homologs at early stages of development. 
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5. PREDICTION OF NONCLASSICAL ORGANIZATION OF SXLPE AND 
SXLPM AND ITS POSSIBLE ROLE IN REGULATION OF SXL EXPRESSION 
 
 
Fig. 12. Early promoter SxlPe is located 5 kb downstream from maintenance promoter 
SxlPm.  
 
 
 
Two of Sxl promoters are TATAless according to Ohler/Fitzgerald criteria 
Two Sxl promoters are located 5 kb apart (Fig. 12).  I have found that both 
promoters may be TATAless promoter according to criteria for TATA consequence 
TATAAA.   
SxlPm is TATAless Motif1 type of promoter (Fig. 13).  It also has two Motif6-
like sequences at position –405 and –470 which is relatively far from TSS and less 
possible to be core promoter motifs. Motif1 TGcaCACTG in SxlPm is located at 
position –4 and almost perfectly fit to Motif1 consensus (C/T)GGTCACTG.  Computer 
program McPromoter confirmed existence of Motif1 in SxlPm promoter (data not 
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shown).  Dr. Ohler performed ETS clustering and individual motif search separate from 
McPromoter results.  He confirmed our finding of Motif1 in SxlPm promoter and did not 
find TATA motif in SxlPm (non published data). 
 
 
 
Fig. 13. TATAless promoter SxlPm has Motif1 sequence at –4 position. 
 
 
SxlPe is DRE/Inr type of promoter and has -30 sequences TTAAATA that was 
thought to be a TATA box (Fig. 14). In order to conform or eliminate this possibility we 
will need to make mutation in those sequences and monitor changes in SxlPe expression  
 
 
 
Fig. 14. SxlPe is DRE/Inr promoter. Presence of TATA-like sequence in SxlPe. 
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in mutants.  We still should consider possibility that Polymerase II uses both TATA and 
DRE/Inr prompter.  
Motif DRE ATcGAT is located at position –22 in SxlPe and fits consensus 
sequence ATGGAT for DRE. Initiator motif TTCAGTCGAGTT is located at –1 
position at SxlPe promoter and perfectly fits to consensus.  Dr. Ohler confirmed our 
finding of DRE/Inr type of promoter by ETS clustering and individual motif search.  
Consensus sequence for TATA box is TATAAA, and according to Ohler/Fitzgerald 
criteria sequence at position –29 TTAAATA is not a TATA box. We need to use 
experimental approach to confirm or deny this possibility.  Dr. Ohler also found DMv1 
motif at position –49 at SxlPe promoter. 
Classical TATA promoter recruits Pol II via TBP, which recruits other TAFs. 
DRE core promoter is different because it recruits not TBP but TBP-related factor Trf2 
or Dref.  Other factors that involved in those core TATAless promoter are remodeling 
factors such as Nurf.  Later we are going to investigate importance of Trf2, Dref and 
Nurf in regulation of Sxl. 
Problems that arise from structure of alternative Sxl promoter 
Two promoters are located 5 kb apart.  Expression of Sxl starts at cycle 12 from 
downstream promoter SxlPe and continues till early minutes of cycle 14.  Expression 
from SxlPm starts at embryonic cycle 13 and continues through adulthood. 
How is this promoter switch regulated?  How does the structure of promoter does helps 
in alternative regulation? 
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 There are at least three levels in regulation of gene expression.  First, I will 
discuss the condensation of chromosomes.  If chromosomes are highly condensed 
(heterochromatin), then almost no genes are expressed or some genes are expressed only 
during replication phase of cell cycle (S-phase).  The same event takes place during 
formation of gametes.  Chromosomes become highly condensed and there is no (or 
almost no) gene expression.  After fertilization several rounds of synchronic replication 
take place.  After each cycle chromosomes become less condensed (most probably 
because distribution of repressor factors along all new nuclei) and then some genes 
begin to express.  They express like heterochromatin genes only in S-phase of cell cycle.  
At cycle 12 there is expression from SxlPe starts, but not from SxlPm. Why? 
Is there regulation SxlPe/ SxlPm on the level of chromosome condensation?  Is 
the concentration of heterochromatic factors on chromosome region of SxlPe less in this 
region in this period of time than in other (including SxlPm) regions?  What 
heterochromatic factors are involved in this regulation?  Is it HP1, the main 
heterochromatic protein?  Does piRNA regulate the difference in SxlPe versus SxlPm 
activation?  Is expression from heterochromatin takes place mostly during replication? Is 
the difference in expression due to the fact that SxlPe is located near replication start 
site?  All these hypotheses have to be tested.  We can plan to compare distribution of 
heterochromatic factors on SxlPe and 5 kb apart on SxlPm.  What character of promoter 
structure does influence on this distribution? 
Second, I will discuss the domain/loop organization.  If on same period of time 
TSS (with core promoter) and activator binding sites are in different functional domains, 
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then expression is suppressed. If remodeling takes place and brings TSS and activator 
sites in the same functional domain, then transcription takes place.  In SxlPe most of 
sisB/Da, the main activators, and binding sites are located rather near the TSS, so special 
looping organization is not necessary in this case.  At the same time, several sisB 
binding sites are located about 1500 bp upstream of SxlPm.  So loop/domain 
organization may be necessary for initiation of expression from SxlPm.  Is the presence 
of specific structural/scanfold proteins necessary for activation of expression from 
SxlPm?  Do they become abundant only after cycle 14 when SxlPm is expressed? 
Other aspect of possible necessity of loop/domain organization for SxlPm 
expression is connected to possible Motif1 structure of SxlPm TATAless promoter.  
Usually Motif1 is accompanied with Motif6 at about -60 positions.  In the case of SxlPm 
two Motif6-like sequences are located at about –400 position.  So loop/domain 
organization may be necessary for activation of SxlPm.  How can we determine the 
validity of this hypothesis?  What factors are necessary for this process? 
Third, I will discuss the difference in primary sequence of SxlPe and SxlPm 
promoter.  SxlPe has binding sites for TF, which are already present in embryos by cycle 
12.  At the same time, SxlPm does not have as many as SxlPe scute/Da binding sites and 
may depend on other factors, which are not present by cycle 12, for its activation. 
SxlPe is DRE/Inr promoter according to Ohler criteria. DRE/Inr promoter is different 
from TATA box promoter in these ways: 
Activation from TATA box promoter starts from recruitment TBP, then other 
TAFs, then polII. 
 47
Activation from DRE/Inr promoter starts from recruitment Trf2 or Dref, then 
alternative TAFs (which are also different from canonical TAFs and include Nurf, 
remodeling factors), then PolII.  
If SxlPe is activated earlier because of DRE/Inr function, then it implies that 
Trf2/Dref and alternative TAFs are more available for SxlPe promoter at this time than 
core promoter elements for SxlPm, which is TATAless, Motif1 promoter.  It is highly 
probable because during gametogenesis classical TAFs are substituted by alternative 
TAFs and they are probably maternally supplied to Drosophila embryos.  Additional 
experiments have to be done to confirm that hypothesis.  Do those alternative TAFs 
regulate cascade of gene activation in early Drosophila embryos and allow only a small 
set of TATAless promoters to become active and expressive before cycle 14?  Do they, 
together with maternally supplied mRNA, provide a blueprint for Drosophila 
development?  We are planning to compare promoter of early Drosophila genes and test 
if they are rich in DRE elements compared to other majority of the genes that are silent 
till cycle 14 (onset of cellularization). 
Why expression from SxlPe shuts down abruptly early at cycle 14?  Which 
factors are involved in this process? How Trf2, Dref and remodeling factors are involved 
in alternative expression from different promoters?  Is there a specific repressor that 
effect only on DRE/Inr SxlPe promoter? What repressor is there? 
I propose to perform a set of experiments to answer all the questions mentioned 
earlier. 
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Unusual expression in mutants 
 
Mutant Trf2#12254 have three X chromosomes in 4 out of 34 counted embryos 
(males and females) (Fig 15). Is there any connection between this phenomenon and sex 
determination? Is it a feature of genetic background? Does Trf2 mutant survive better in 
3X? These are questions for future research.  
 
 
 
Fig.15. Expression of SxlPe is observed from three X chromosomes in Trf2 
mutant#12254.  
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6. DISCUSSION*  
 
SxlPe switches on in females because XX embryos have twice the amount of 
XSE activators as XY embryos.  How this two-fold difference in XSE proteins is 
converted into an all-or-nothing transcriptional response at SxlPe is the central question 
in primary sex determination.  The traditional concept of the sex determination signal as 
the X chromosome to autosome ratio, X:A, led to the hypothesis that the male/female 
difference in XSE proteins is amplified through the actions of inhibitors encoded by 
autosomal signal elements, or ASEs (see Schutt and Nothiger, 2000; Gilbert, 2006).  In 
this view, Dpn and other ASE proteins amplify the signal by preferentially titrating XSE 
proteins in XY embryos and by competing with XSE proteins for binding to SxlPe 
(Parkhurst et al., 1990; Paroush et al., 1994; Schutt and Nothiger, 2000; Louis et al., 
2003).  An alternative idea, based on the thesis that XSE dose is the sex-determining 
signal, and on the finding that dpn is the only significant ASE, is that signal-
amplification might occur primarily through combinatorial interactions between XSE 
activators and their maternally-supplied cofactors at SxlPe (Cline, 1993; Erickson and 
Cline, 1993; Barbash and Cline, 1995; Yang et al., 2001; Wrischnik et al., 2003; 
Erickson and Quintero, 2007).  Repression by DNA-binding proteins is important in 
combinatorial schemes, but as a kind of fine-tuning control, rather than as the primary 
cause of dose-sensitivity. 
A full understanding of the role of negative regulators in the dose-sensitive  
___________ 
*Reprinted from Developmental Biology 323(2), Lu H, Kozhina E, Mahadevaraju S, Yang D, Avila 
FW, Erickson JW, Maternal Groucho and bHLH repressors amplify the dose-sensitive X chromosome 
signal in Drosophila sex determination, 248-260, Copyright © 2008, with permission from Elsevier 
Inc.  
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control of SxlPe requires the identification and characterization of the cis-regulatory 
sequences controlling repressor binding as well as the trans-acting factors working 
through those sites.  In the following paragraphs we discuss our findings that Dpn, and 
other, presumably maternal, bHLH proteins bind SxlPe and act in conjunction with the 
corepressor, Gro, to define and maintain the threshold concentrations of XSE proteins 
needed to activate SxlPe.  Our data suggest that neither the classical notion of 
amplification by titration, nor the activator-centered alternative, adequately explain how 
XSE dose is assessed.  Rather they indicate that repression at the level of DNA, or 
chromatin, is a central aspect of XSE signal amplification.  We conclude with a model 
for how Gro-mediated repression could be modulated by XSE function to generate the 
dose-sensitive control of SxlPe. 
Canonical and non-canonical bHLH repressor-binding sites at SxlPe 
Although SxlPe has two typical DNA-binding sites for HES family proteins 
(Hoshijima et al., 1995; Winston et al., 1999), their role in Sxl regulation in vivo had not 
been examined.  Our analysis confirmed that the canonical CACGCG sites centered at -
108 and -119, bind HES-family repressors in the embryo, but also revealed that a non-
canonical site 3, CACACT, at -160 mediates repression in its normal promoter context.  
Although CACACT had not been previously reported as a HES-binding site, 
considerable evidence points to the in vivo importance of DNA-binding sites with less 
than optimum binding affinity.  N-boxes, CACNAG, bind HES proteins with lower 
affinity than the optimal CACG(T/G)G sequences, but are known to mediate repression 
of several genes in mammalian cells, and the variant CACGCA appears to bind control 
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repression of Math1 in mice (Iso et al., 2003).  The same applies to bHLH activators as 
illustrated by our finding that the bHLH activator Sc/Da exerts most of its dose-sensitive 
effects at SxlPe through non-canonical DNA-binding sites (Yang et al., 2001). 
Cis-acting mutations implicate additional bHLH repressors in Sxl regulation 
We found that mutations in the Dpn-binding sites had stronger and earlier effects 
on SxlPe activity than did complete loss of dpn function (Table 1).  The simplest 
explanation for this finding is that additional bHLH repressors work through the same 
sequences as Dpn to control SxlPe.  The additional repressors seem likely to be 
maternally supplied.  This argument is based on timing, the cis-acting Dpn-site 
mutations can affect SxlPe-lacZ expression in XX embryos as early as nuclear cycle 10 
or 11, when few zygotic genes are active (albeit those active include the XSEs scute and 
sisA).  And on the results of sensitive and unbiased genome-wide genetic screens that 
showed dpn to be the only zygotically expressed inhibitor of SxlPe of any significance 
(Barbash and Cline, 1995; Wrischnik et al., 2003). 
Hey is a maternal repressor of SxlPe  
The prediction that bHLH repressors other than Dpn regulate SxlPe was 
confirmed by our discovery that maternal Hey functions as a negative regulator of SxlPe.  
Befitting its maternal origins, hey acts earlier than dpn, as evidenced by increased Sxl 
expression in cycle 12 XX embryos and ectopic activation in cycle 13 XY Heymat- 
mutant embryos.  However, Heymat- mutants, unlike dpn- embryos, accumulate no 
detectable Sxl protein in males suggesting either that the single available Hey mutation is 
not a null allele or that still other bHLH repressors regulate SxlPe.  The later possibility 
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is also suggested by the finding that mammalian Hey homologs do not appear to interact 
directly with Gro/TLE proteins (Iso et al., 2001).  One promising candidate bHLH 
repressor is Her (Hes-related, CG5927).  Her protein is encoded on the X chromosome 
and the gene is maternally expressed (Moore et al., 2000), placing this WRPW-
containing HES family member in the correct cellular context to regulate SxlPe.  
Unfortunately no Her deletions or point mutations are currently available to test its 
possible function at Sxl. 
Gro-dependent repression predominates at SxlPe 
The first indication that repression is likely to be a quantitatively important part 
of primary sex determination was the finding that XY gromat- embryos expressed high-
levels of ectopic Sxl protein (Paroush et al., 1994).  This initial study of gro and Sxl was 
limited in scope because X-ray induction of germline clones could generate only a 
limited number of gromat- embryos.  Using high efficiency FLP/FRT-mediated 
recombination (Chou and Perrimon, 1996) we analyzed in detail the effects of maternal 
gro on Sxl protein and on SxlPe activity.  Our findings confirmed that loss of maternal 
gro leads to ectopic SXL in XY embryos and showed that this is caused by activation of 
SxlPe in XY embryos.  Our results differed from the initial study in one important 
respect.  Whereas Paroush et al., (1994) reported that SXL levels were indistinguishable 
in XY and XX gromat embryos, we found that Sxl mRNA and protein were expressed at 
higher levels in XX embryos at all stages of embryogenesis, even when corrected for the 
copy number of the X-linked Sxl gene.  This has important implications for function, as 
it means that SxlPe responds differently to the one-X and two-X doses of XSEs even in 
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the absence of gro-mediated repression.  The ability of the promoter to distinguish XX 
from XY is also evident from our finding that SxlPe was always activated at least one 
cycle earlier in female than in male embryos when repression was compromised or 
eliminated (Figs. 5 and 6, Table 1).  
The best evidence that the pleiotropic gro protein acts directly at SxlPe, rather 
than on than other maternal or zygotic genes that influence SxlPe activation, is that 
maternal groE48 and the 1-2-3-4- Dpn-binding site mutations have nearly identical effects 
on SxlPe, eliciting premature activity in XX embryos and ectopic expression in XY cells 
(Table 1).  While the somewhat depressed state of the 1.4 kb SxlPe-lacZ transgenes 
prevented precise comparisons, our data suggest that most, if not all, of the repressive 
effects of maternal gro, and of the cis-acting repressor sites, can be explained by the 
recruitment of Gro to SxlPe by bHLH proteins.  This suggests that several other 
hypothesized methods of HES-mediated repression, including competition between Dpn 
and Sc/Da for DNA-binding (Louis et al., 2003), or orange-domain dependent inhibition 
of Scute function by Dpn (Dawson et al., 1995) are likely to have little quantitative 
importance at SxlPe, unless such interactions are also directly related to Gro function 
(see below).  The predominant corepressive role of Gro is also consistent with the 
findings that the corepressors dCtBP and Sir2, which can associate with HES proteins, 
do not influence Sxl expression (Poortinga et al., 1998; Zhang and Levine, 1999; Astrom 
et al., 2003).  
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Inhibition by sequestration of activators? 
A means of repression that is independent of Gro and DNA binding is titration, 
or the sequestration of activators into non-functional heterodimers.  Long a staple of 
models for how the the X:A ratio might be read (see Parkhurst et al., 1990; Schutt and 
Nothiger, 2000; Gilbert, 2006), titration schemes have found mathematical corroboration 
(Louis et al., 2003), but little experimental support.  To our knowledge, the only 
evidence for sequestration of an XSE by an ASE protein is a non-reciprocal two-hybrid 
interaction between Dpn and SisA (Liu and Belote, 1995; Louis et al., 2003).  An 
interaction that we did not observe with a different two-hybrid system (Fields and Song, 
1989; unpublished data).  Negative regulation at the level of DNA, in contrast, is 
supported by the known functions of the proteins, by the initial stochastic activation 
pattern of each copy of SxlPe (Erickson and Cline, 1998), and by the strong effects of 
maternal gro and the Dpn-binding site mutations.  Nonetheless, our data do leave open 
the possibility that some XSE signal amplification could occur via sequestration of 
activators.  If so, we suggest that maternally-supplied Emc, the sole example of an 
inhibitor with a demonstrated ability to heterodimerize with an XSE protein 
(Campuzano, 2001), is likely the amplifying factor, rather than Dpn or an undiscovered 
ASE. 
Groucho and the control of the SxlPe switch 
SxlPe responds to threshold concentrations of XSE activators.  Loss of maternal 
gro, or of Dpn-binding site function, causes premature onset of Sxl transcription in XX 
embryos and strong ectopic expression in XY embryos.  Loss of dpn protein function, in 
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contrast, has virtually no effect on Sxl in females while causing relatively late, and low-
level, Sxl expression in males.  These findings suggest that Gro and associated maternal 
repressors directly mediate the initial activation threshold at SxlPe, and that the same 
factors, plus the ASE protein Dpn, then act to maintain the threshold at appropriate 
values throughout the X-counting process (see Erickson and Cline, 1993; Barbash and 
Cline, 1995).  An important mechanistic point is that while Gro is not needed for SxlPe 
to sense male/female differences in XSE doses, it is required to convert the differences 
into a robust all-or-nothing transcriptional response.  How might Gro, acting at the level 
of DNA, or chromatin, amplify the XSE signal and ensure proper operation of the SxlPe 
switch? 
The predominant model for Gro corepressor function; recruitment to DNA by 
repressors, oligomerization, spreading, and recruitment of histone deactylases, to 
generate extended regions of inactive chromatin explains how Gro can function as a 
dominant long-range repressor (Barolo and Levine, 1997; Chen and Courey, 2000; 
Martinez and Arnosti, 2008).  The notion of potent long-range silencing, however, fits 
poorly with our understanding of Sxl regulation.  First, short-range repression should 
suffice at SxlPe.  The repressor-binding sites are located close to the transcription 
initiation site, and they can mediate effective repression of Sxl by ectopic derivatives of 
Hairy that carry Gro-independent ‘short-range’ repression domains (Jimenez et al., 
1997).  Second, Gro-mediated repression at SxlPe is dynamic, reversible, and relatively 
weak.  Established early in both sexes, repression is overcome in XX embryos during 
cycle 12.  Even in XY embryos, where SxlPe normally remains inactive, loss of dpn 
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function causes a partial reversal of repression during cycles 13 and 14.  Transient 
repression by Gro is not unique to Sxl.  As discussed by Jennings et al., (2007), and 
Martinez and Arnosti, (2008) reversible Gro-mediated local repression is commonly 
found at loci that are expressed in dynamic developmental contexts suggesting that Gro 
likely represses transcription by more than one mechanism. 
Models for Gro-mediated repression invoking interactions with the mediator 
complex or RNA polymerase (see Buscarlet and Stifani, 2007) fit better with aspects of 
Sxl regulation, but, like the dominant-silencing model, do not offer ready explanations 
for how Gro might control the switch-like response of SxlPe.  In contrast, a recent model 
for Gro function invoking direct associations between Gro and chromatin as a necessary 
step in repression (Sekiya and Zaret, 2007) appears to be both compatible with transient 
local repression and suggestive of a means by which Gro might ‘amplify’ the XSE 
signal. 
Sekiya and Zaret’s (2007) key finding was that the mammalian Gro/TLE protein, 
Grg3, represses transcription by creating a 3 to 4 nucleosome region of poorly accessible 
chromatin that inhibits binding by transcriptional activators.  Surprisingly, Grg3 is not 
recruited directly by DNA-binding repressors.  Instead, Grg3 first associates with 
chromatin via interactions with histones to form an open nucleosome array.  Gro-
interacting transcription factors, including the bHLH protein Hes-1, then bind their DNA 
sites in the array enabling Grg3 recruitment and formation of the repressive chromatin 
complex (Sekiya and Zaret, 2007).  We propose that the requirement that Gro bind 
nucleosomal histones, combined with Gro’s low affinity for highly acetylated chromatin 
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(Edmondson et al., 1996; Chen and Courey, 2000) provides the elements of a possible 
feedback mechanism that could work in the early embryo to amplify the female/male 
difference in XSE proteins into a reliable developmental signal (Fig. 16).   
A model for Gro-mediated amplification of dose-sensitive signals  
The basic tenets of our model for SxlPe regulation are:  1) The initial threshold 
XSE concentration needed to activate SxlPe is set by the translation products of 
maternally-supplied gro mRNA acting in conjunction with the products of maternally- 
 
 
 
Fig. 16.  Model for dose-sensitive regulation of SxlPe.  (Top) Gro and other products of 
maternally supplied mRNAs establish initial threshold XSE concentrations for SxlPe 
activation.  XX embryos exceed threshold [XSE] in cycle 12.  Activation of SxlPe 
inhibits Gro-mediated repression leading to increased Sxl mRNA in cycles 13 and 14.  
(Bottom) Gro and other maternal products maintain repression potential above XY XSE 
concentrations until cycle 13.  Zygotic expression of Dpn combined with maternal Gro 
and other products thereafter maintains repression potential above XY [XSE].  XSE 
mRNAs are degraded early in cycle 14.  Time scale; cycle 13 is 18 min long and begins 
112 min after fertilization (Foe et al., 1993). 
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supplied mRNAs encoding bHLH repressors.  2) The initial SxlPe activation threshold is 
crossed first in XX embryos because they possess twice the amount of XSE proteins 
present in XY embryos.  3) Activation of Sxl transcription leads to acetylation of 
histones at SxlPe.  Histone acetylation decreases the ability of Gro to bind chromatin 
reducing Gro’s ‘repression potential’ and allowing the XX dose of XSE proteins to more 
effectively stimulate transcription from SxlPe.  4) In XY embryos, continued translation 
of maternal mRNAs and the activation of zygotic dpn adjust the SxlPe activation 
threshold upward so that it remains above the XSE concentrations present in male 
embryos in cycles 13 and 14 (Fig. 7).  The net result is a form of signal amplification via 
positive feedback.  Once initiated in XX embryos, Sxl transcription gains in strength 
from the interacting effects of rising XSE levels and decreased potential for Gro-
mediated repression.  The initial failure to activate SxlPe in XY embryos, in contrast, 
leaves Gro function unabated, so that the single-X dose of XSEs can never exceed the 
growing SxlPe activation threshold.   
Our model for operation of the SxlPe switch, with its emphasis on signal 
amplification by modulation of corepressor function, is distinct from traditional titration 
schemes (Parkhurst et al., 1990; Schutt and Nothiger, 2000; Gilbert, 2006), and from 
composite models invoking titration, DNA-binding site competition, or interactions 
between multiple activators (Yang et al., 2001; Louis et al., 2003).  Its most novel aspect 
is the feedback mechanism in which high XSE protein concentrations and transcription 
from SxlPe inhibit Gro function in females.  The specific proposal that histone 
acetylation, occurring as a consequence of transcription and XSE activator binding 
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(reviewed in (Shahbazian and Grunstein, 2007) inhibits Gro-mediated repression is 
speculative but based on the finding that the yeast Gro/TLE protein Tup1 does not bind 
highly acetylated histones (Edmondson et al., 1996; see Chen and Courey, 2000; Sekiya 
and Zaret, 2007).  Feedback regulation, however, need not be limited to chromatin 
modifications.  XSE proteins could also decrease the repression potential of Gro by 
competing with Dpn, Hey, and other repressors for overlapping DNA-binding sites, or 
by direct interference with Gro or repressor function.  The C-terminal VWRPY motif of 
the XSE protein Runt can interact with Gro, raising the possibility that much of Runt’s 
positive role at SxlPe is due to its ability to directly antagonize repression (Aronson et 
al., 1997). 
One question our model does not directly address is what prevents stochastic 
fluctuations in XSE levels from causing stable activation of SxlPe in some XY nuclei?  
The one nuclear cycle lag in Sxl activation seen in XY compared to XX nuclei when 
repression is compromised by mutation (Figs. 5 and 6, Table 2), hints that literal two-
fold differences in XSE concentrations may be sufficient to reliably signal an on-or-off 
response for a limited period of time.  The regulatory scheme may also provide a kind of 
double-check against activation due to random variations in XSE levels.  Stable 
expression of SxlPe would require not only that the promoter be activated, but also that 
it be turned on at sufficiently high levels to establish the feedback mechanism.  XX cells 
meet both criteria, but the occasional XY nucleus that surpassed threshold XSE levels 
would likely fail to reinforce the initial event because the single Xs of it and its 
neighbors would supply insufficient XSE products to do so (Gregor et al., 2007).  On the 
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other hand, the discriminatory power of the system would likely be increased by even a 
small increase in the relative female/male XSE signal prior to the onset of feedback 
regulation.  Plausible early amplification mechanisms include titration of Scute by 
maternal Emc, and combinatorial effects due to multiple XSE activator-binding sites 
(Wang et al., 1999; Louis et al., 2003; Veitia, 2003). 
Although our focus here is on Sxl, the idea that transcriptional activation could 
be a kind feedback control of Gro-activity may be applicable to other genes and systems 
that respond to small or transient changes in regulatory proteins.  As discussed by 
(Jennings et al., 2007) Gro acts in a dynamic fashion to sharpen spatial expression 
boundaries during segmentation and to precisely control periodic patterns expression in 
neuroblast multiplication and during vertebrate somitogenesis.  A reversible feedback 
mechanism relying on general properties of transcriptional activation rather than specific 
interactions might have considerable evolutionary flexibility. 
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7. SUMMARY AND CONCLUSIONS 
 
1. Maternally supplied Gro is responsible for amplification difference in dose of 
activator transcription factors. 
2. Three new repressors of SxlPe are identified: 
 Hey, which is bHLH maternal transcription factor  
 bHLH Cwo 
 Prooncogene Myc 
3. SxPe promote is predicted to be TATAless DRE/Inr promoter. Importance of core TF 
Trf2 and Dref for regulation of SxlPe is discussed. SxlPm is predicted to be Motif1 
(Motif6?) TATAless promoter. 
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APPENDIX 
 
Lack of maternally contributed Big brother does not influence SxlPe expression 
Two closely related (Fig. 17) proteins Bro (Brother) and Bgb (Big Brother) are 
transcriptional co-activators, analogs to human core binding factors, beta subunit.  They 
interact with runt domain proteins Runt and lozenge (Canon and Banerjee, 2000).  Runt 
domain is also found in p53 protein, one of the core proteins that prevent cancer 
development in human.  
 
 
Bgb        mmNEAALANMIP-YDTIGLYEQPKPRFIFKMPRVVPDQKSKFESDELFRRLSRESEVRYTGY  61 
             + AA+  MIP Y+ + +YEQPKPRFIFKMPRVVPDQ+SKF+SDELFRRLSRESEVRYTGY 
Bro  mhhhqnlgDAAAMNGMIPPYEAMAMYEQPKPRFIFKMPRVVPDQRSKFDSDELFRRLSRESEVRYTGY  68 
 
Bgb         RERSIEERQVRFMNGCREGHTEASFVASGTNLQLVFNANQNPYLHDKECDFDKEHGKVHI  121 
            RER++EER++RF+N CR+G+ E S VASGTNLQL FNAN NPY  +++CDF++E GKVH+ 
Bro         RERAMEERRMRFVNDCRKGYAEISMVASGTNLQLYFNANHNPYAQEQDCDFERERGKVHL  128 
 
Bgb         KSYFIMNGVCVRFRGWIDLERLDGVGCLEYDERRAMHEDAILRDQIDRYNQRLREFEDTK  181 
            +S FIMNGVCVRFRGW+DL+RLDG  CLE+DE+RA  EDA L++QI  YNQR+ E   ++ 
Bro         RSSFIMNGVCVRFRGWVDLDRLDGAACLEFDEQRAQQEDAQLQEQIQSYNQRMAE---SR  185 
 
Bgb         RAYRDNRQDEMEAVRRGVASGGIGVGASMW  211 
            R Y   +    +   RG    G+  G   W 
Bro         RIYHTPQTPPEDHHHRG--GPGLPRGPMGW  213 
 
Fig. 17. Bro and Bgb are highly similar proteins. Alignment of Bro(AAF47538) and Bib 
(AAF47533) proteins. NCBI BLAST score is 77% Positive163/210. 
 
 
 
Runt domain proteins can act as activators or as repressors.  We speculate that 
this phenomenon can be explained by the fact that runt DNA-binding domain acts to 
clamp or encircle the DNA target in order to stabilize the protein-DNA complex.  This 
domain has an immunoglobulin-like fold consisting of a beta-sandwich of 9 strands in 
two sheets with a Greek key topology (Berardi et al., 1999).  We speculate that in the 
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case of SxlPe expression Runt/Bgb or Runt/Bro complex are most important for 
stabilization of activator factors and so that is how it works as transcriptional activator.  
Bgb is a maternally supplied protein that is distributed ubiquitously during stages 
1-3.  According to (Golling et al., 1996) data Bro is also expressed maternally which is 
contradicted to (Fujioka et al., 1996) data who confirmed that only Bgb is expressed 
maternally. Both Bro and Bgb are expressed also zygoticaly and Bro function only in 
early embryos.  Bgb mRNA (zygotic) begins to accumulate ubiquitously during 
blastoderm stage and then can be seen only in embryonic brain and ventral nerve cord 
from stage 11 (flybase, BDGP, SD 08175).  This pattern of expression implies that 
function of these two closely related genes can be partly redundant.  
Expression of SxlPe in germline Bgb clones 
To determine if only one of the maternally supplied co-activator Bgb take part in 
regulation of SxlPe expression we generated germline clone Bgbmat- and assayed its 
effect in embryos derived from Bgbgermline x oNBgb/+ . 
 
 
 
 
 
 
Fig. 18. Bgb mutant (Bloomington#13509) is a P element insertion P{SUPor-
P}Bgb[KG03779] at about 20 bp downstream transcriptional start site and about 300 bp 
upstream the first ATG start codon.   
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I used Bgb mutant (Bloomington#13509) which is a P element insertion at about 
20 bp downstream transcriptional start site and about 300 bp upstream the first ATG 
start codon (Fig 18.)  To create Bgb FRT line I crossed 
# Bloomington5750 Gl,st,FRT(w+)/TM3  x  oNBgb(w+)/TM3 
            O  
and selected progeny Gl,st,FRT(w+)/Bgb(w+)  x oN #5750 Gl,st,FRT(w+)/TM3   
             O  
for recombinant    oN Bgb(w+)FRT(w+)/TM3 which has similar to wild-type red w(+) 
eyes in compare to oNBgb(w+)/TM3 brownish or oN FRT(w+) orange eyes. 
I confirmed oNBgb(w+)FRT(w+)/TM3 genotype by crossing them with wild-
type oNw1118 flies and obtained all type of progeny oN Bgb(w+)/TM3 brown eyes oN 
FRT(w+)/TM3 orange eyes oN Bgb(w+) FRT(w+)/TM3 red eyes and +/+ white eyes. 
 
 
 
Fig. 19. Creation of homozygous Bgb germline clones. 
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To create germline clone I followed the protocol of (Chou and Perrimon, 1996) 
(Fig. 19).  Germline clones were generated following heat treatment of female larvae of 
following genotype P{hsFLP}, y1w1118/w1118; P{w(+)FRT 2A} ,Bgb/P{w(+)FRT}2A, 
ovoD. Females bearing recombinant germlines were crossed to Bgb/TM3 males. 
In germline clone expression of SxlPe starts at appropriate time (Fig. 20) at cell 
cycle 12.  There was no ectopic expression of SxlPe during earlier cycle 9, 10 or 11. 
Cycle 12                      1embryo”–“ just after mitosis 
                          oN       3 embryos ”–“ 
                          oN       2 embryos ”–“ about 6 dots per embryo 
                  female       4 embryos “+” more the 30% of nucleus 
In some of the male embryos at cycle 12 there were 3-6 nuclear with ectopically 
expressed SxlPe, which is less then 2% of the nuclear.  If negative regulator are able to  
 
 
 
Fig. 20. Time course of SxlPe activation in maternal BgbKG03779 mutant embryos. 
Bgbmat- do not influence on SxlPe time course. Mutant Bgbmat- embryos were stained 
following in situ hybridization. Black and white panels show surface views of 
embryonic nuclei at indicated nuclear cycles. Dots represent nascent transcripts from the 
X-linked Sxl locus. Color panels show peak accumulation of SxlPe-derived mRNA in 
early cycle 14. Embryos were progeny of females with BgbKG03779  FRT/ 
BgbKG03779  FRT germline and BgbKG03779 /TM3 males. 
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amplify the female/male difference during the time of cycle12 – early cycle 14 then 
these misexpressed male nuclear are subject for complete later repression. 
At cycle 13 half of male embryos (9 out of 19) expressed SxlPe in 3-6 nuclei, 
which is less then 2% of the nuclei.  In female embryos (15 female embryos of cycle 13 
were examined) SxlPe is expressed at obviously normal level at cycle 13.  Some of 
female embryos expressed SxlPe not in all but in 80% of the embryo, and about 20 
express SxlPe in only one dot, which is correspondent to only one out of two female X 
chromosomes.  This pattern of expression is similar to wild-type variation of expression.  
Because both Bro and Bgb are able to bind Runt (Li and Gergen, 1999) and both are 
expressed during blastoderm stage (Fujioka et al., 1996), the stage that is critical for 
SxlPe activation, it is reasonable to speculate that their function is redundant.  So 
zygoticay expressed Bro completely compensate lack of maternally supplied Bgb in this 
case.  
At cycle 14 SxlPe in Bgbmat- is expressed at normal level in male and female 
embryos.  This fact is one additional conformation of the model that both proteins act as 
transcriptional co-activator of SxlPe and their function is mostly redundant. 
Accumulation of mRNA in Bgb germline started to become visible at cycle 13 and got 
it’s maximum level by 5 min cycle 14 (Fig 20), the same as in wild-type embryos. 
There was no difference in Sxl expression on the protein level also.  In the 
progeny of germlene Bgb/Bgb with cross of wild-type males w1118, expression of Sxl 
protein started at cycle 14 in female embryos. Approximately half of embryos, which 
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were 43 out of 36, did not express Sxl, which is normal for male embryos (data not 
shown). 
So our data support the conclusion that lack of maternally contributed Bgb do not  
influence onto Sxl expression as on protein, as on level of nascent transcripts, as on level 
of mRNA expression.   
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